Alexander Zurcher - Molecular Partners COO Board
| MOLN Stock | CHF 3.40 0.08 2.41% |
Insider
Alexander Zurcher is COO Board of Molecular Partners AG
| Phone | (41) 44 755 77 07 |
| Web | www.molecularpartners.com |
Molecular Partners Management Efficiency
The company has return on total asset (ROA) of 0.3163 % which means that it generated a profit of $0.3163 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6246 %, meaning that it generated $0.6246 on every $100 dollars invested by stockholders. Molecular Partners' management efficiency ratios could be used to measure how well Molecular Partners manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Alexander Khatuntsev | Idorsia | 45 | |
| Guy MD | Idorsia | 67 | |
| Oliver MBA | Evolva Holding SA | 54 | |
| Hazel Winchester | COSMO Pharmaceuticals SA | 52 | |
| Andr Muller | Idorsia | 60 | |
| Alessandro LLM | COSMO Pharmaceuticals SA | 60 | |
| Markus Riederer | Idorsia | 61 | |
| Philipp Frech | Evolva Holding SA | N/A | |
| Luigi Longo | COSMO Pharmaceuticals SA | 44 | |
| Andrew Weiss | Idorsia | 55 | |
| Niall Donnelly | COSMO Pharmaceuticals SA | 51 | |
| Christoph Boss | Idorsia | 54 | |
| Biagio Vigano | COSMO Pharmaceuticals SA | 49 | |
| Kaspar Mueller | Evolva Holding SA | 60 | |
| Davide Malavasi | COSMO Pharmaceuticals SA | 50 | |
| Christian Wichert | Evolva Holding SA | N/A | |
| Marco Lecchi | COSMO Pharmaceuticals SA | 59 | |
| Ngo Nhan | COSMO Pharmaceuticals SA | 44 | |
| Julien LLM | Idorsia | 44 | |
| Anne Vos | Evolva Holding SA | 59 | |
| Giulio Evangelisti | COSMO Pharmaceuticals SA | 53 | |
Management Performance
| Return On Equity | 0.62 | |||
| Return On Asset | 0.32 |
Molecular Partners Leadership Team
Elected by the shareholders, the Molecular Partners' board of directors comprises two types of representatives: Molecular Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molecular. The board's role is to monitor Molecular Partners' management team and ensure that shareholders' interests are well served. Molecular Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molecular Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Steiner, VP Research | ||
| Thomas Schwerzmann, VP HR | ||
| Michael Stumpp, Ex CoFounder | ||
| Andreas EMBA, Advisor | ||
| Alexander Zurcher, COO Board | ||
| Seth Lewis, Communications Relations | ||
| Patrick Amstutz, CEO, CoFounder | ||
| Renate Gloggner, Ex Board | ||
| Michael Pitzner, Compliance Counsel |
Molecular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Molecular Partners a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.62 | |||
| Return On Asset | 0.32 | |||
| Profit Margin | 0.62 % | |||
| Operating Margin | 0.61 % | |||
| Current Valuation | (39.23 M) | |||
| Shares Outstanding | 36.04 M | |||
| Shares Owned By Insiders | 14.13 % | |||
| Shares Owned By Institutions | 45.01 % | |||
| Price To Earning | 2.02 X | |||
| Price To Book | 0.89 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Molecular Stock analysis
When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |